1-s2.0-S0010440X15303175-main
Transcript of 1-s2.0-S0010440X15303175-main
-
7/25/2019 1-s2.0-S0010440X15303175-main
1/20
Body Focused Repetitive Behavior Disorders: Significance of Family History
Sarah A. Redden, Eric W. Leppink, Jon E. Grant
PII: S0010-440X(15)30317-5
DOI: doi:10.1016/j.comppsych.2016.02.003
Reference: YCOMP 51629
To appear in: Comprehensive Psychiatry
Please cite this article as: Redden Sarah A., Leppink Eric W., Grant Jon E., BodyFocused Repetitive Behavior Disorders: Significance of Family History, ComprehensivePsychiatry (2016), doi:10.1016/j.comppsych.2016.02.003
This is a PDF file of an unedited manuscript that has been accepted for publication.As a service to our customers we are providing this early version of the manuscript.The manuscript will undergo copyediting, typesetting, and review of the resulting proof
http://dx.doi.org/10.1016/j.comppsych.2016.02.003http://dx.doi.org/10.1016/j.comppsych.2016.02.003http://dx.doi.org/10.1016/j.comppsych.2016.02.003http://dx.doi.org/10.1016/j.comppsych.2016.02.003 -
7/25/2019 1-s2.0-S0010440X15303175-main
2/20
b f i i bli h d i i fi l f Pl h d i h d i
CCEP
TEDM
ANUSC
RIPT
ACCEPTED MANUSCRIPT
Body Focused Repetitive Behavior Disorders: Significance of Family History
Sarah A. Redden, BA
Eric W. Leppink, BA
Jon E. Grant, JD, MD.
Department of Psychiatry & Behavioral Neuroscience, University of Chicago,
Pritzker School of Medicine, Chicago, IL, USA
Address correspondence to:
Jon E. Grant, J.D., M.D., M.P.H.
Department of Psychiatry & Behavioral Neuroscience
University of Chicago, Pritzker School of Medicine
5841 S. Maryland Avenue, MC-3077, Chicago, IL 60637
Telephone Number: 773-834-1325; Fax: 773-834-6761;
Email: [email protected]
-
7/25/2019 1-s2.0-S0010440X15303175-main
3/20
CCEP
TEDM
ANUSC
RIPT
ACCEPTED MANUSCRIPT
Running title: Family history in trichotillomania and skin picking
Abstract
Background:The significance of family history in body-focused repetitive behavior disorders
(BFRBs) (i.e. trichotillomania and skin picking) has received scant research attention. We sought
to understand the clinical and cognitive impact of having a first-degree relative with a BFRB or a
substance use disorder (SUD).
Methods:265 participants with BFRBs undertook clinical and neurocognitive evaluations.
Those with a first-degree relative with a BFRB or a SUD were compared to those without on a
number of clinical and cognitive measures.
Results:77 (29.1%) participants had a first-degree family member with a BFRB and 59 (22.2%)
had a first-degree family member with a SUD. In terms of clinical severity, the amount of time
spent picking or pulling per day in the past week was higher among those with a first-degree
relative with a SUD. There was a higher rate of ADHD and higher HAM-D scores among those
with a positive family history of a SUD. There were no significant cognitive differences based on
family history.
-
7/25/2019 1-s2.0-S0010440X15303175-main
4/20
-
7/25/2019 1-s2.0-S0010440X15303175-main
5/20
CCEP
TEDM
ANUSC
RIPT
ACCEPTED MANUSCRIPT
drug use disorders).14
Similarly, a study of 34 patients with skin picking disorder found lifetime
alcoholism in 37.5% of first-degree relatives.22
Thus, the existing literature suggests that BFRBs run in families where we also see high
rates of BFRBs and SUDs. Existing data, however, do not provide information as to what, if
anything, these types of familial associations may mean for the person with trichotillomania or
skin picking disorder. Therefore, understanding the clinical and neurocognitive aspects of
BFRBs and how these factors differ between individuals with different types of family histories
may be important in order to identify potential clinical and cognitive subtypes, improve
neurobiological models, and optimize treatment. The purpose of this study is to investigate
whether adults with BFRBs with a first-degree relative with a BFRB or a SUD have a different
clinical presentation than those without, and whether analysis of different familieshistories has
any clinical relevance.
2. Materials and methods
2.1 Subjects
-
7/25/2019 1-s2.0-S0010440X15303175-main
6/20
CCEP
TEDM
ANUSC
RIPT
ACCEPTED MANUSCRIPT
implementation of any treatments. Data were collected from September 2006 through January
2015.
2.2 Assessments
Participants were asked about the presence of lifetime BFRBs and SUDs (which included
alcohol and drug use disorders, but not nicotine) in all first-degree relatives. As some picking
and pulling behavior may occur in family members without rising to the level of a disorder, only
severe picking resulting in chronic lesions and pulling resulting in noticeable alopecia met the
definition of skin picking disorder or trichotillomania in a family member. Substance use
disorders were defined as the chronic use of drugs or alcohol resulting in either noticeable social
and occupational dysfunction or the need for a twelve-step program or formal treatment. All
information about relatives came from the proband. No direct evaluations of the first-degree
relatives were performed.
Current and lifetime psychiatric comorbidity was assessed using the Structured Clinical
Interview for DSM-IV (SCID) disorders23
and valid and reliable SCID-compatible modules for
-
7/25/2019 1-s2.0-S0010440X15303175-main
7/20
CCEP
TEDM
ANUSC
RIPT
ACCEPTED MANUSCRIPT
In terms of formal measures, all participants completed the following at baseline:
Clinical Global Impression- Severity (CGI).25
The CGI is a valid and reliable, 7-item
scale used to assess symptom severity. It uses a Likert-scored scale with 1 = not ill at all to 7 =
among the most extremely ill. The scale was used to assess only the severity of theBFRB
symptoms.
Sheehan Disability Scale (SDS).26The SDS is a valid and reliable, three-item, self-report
scale assessing psychosocial functioning in three areas of life: work, social or leisure activities,
and home and family life. Scores on the SDS range from 0 to 30.
Quality of Life Inventory (QoLI).27
The QoLI is a valid and reliable 16-item, self-report
positive psychology scale assessing areas of life such as health, love, work, recreation, home,
friendships, self-esteem, and standard of living.
Current depressive and anxiety symptoms were assessed using the 17-itemHamilton
Depression Rating Scale28
and theHamilton Anxiety Rating Scale,29
respectively.
2.3 Cogniti ve Testing
-
7/25/2019 1-s2.0-S0010440X15303175-main
8/20
CCEP
TEDM
ANUSC
RIPT
ACCEPTED MANUSCRIPT
2.4 Data Analysis
Based on the family history, participants were categorized into the following groups:
family history positive/negative for a BFRB and family history positive/negative for a SUD. We
used one-sample Kolmogorov-Smirnov Tests to test for normal distribution for all continuous
variables. Potential differences between the groups were explored using analysis of variance
(ANOVA) for normally distributed variables, while Mann-Whitney Tests were used to determine
significant differences in the variables that were not normally distributed. Chi-square tests were
used for non-parametric tests as appropriate. A Bonferroni correction was conducted to correct
for multiple comparisons. With seven clinical variables, significance was defined as the
Bonferroni adjusted p
-
7/25/2019 1-s2.0-S0010440X15303175-main
9/20
CCEP
TEDM
ANUSC
RIPT
ACCEPTED MANUSCRIPT
histories as only 11 (4.2%) had at least one first-degree relative with both a BRFB and SUD.
Clinical characteristics of those with and without a positive family history are contrasted in Table
1.
In terms of clinical measures, nothing was significant based on the Bonferroni
correction; however, those with a first-degree relative with a SUD reported more time each day
pulling or picking and greater depression symptomatology. There were also no statistically
significant clinical differences between adults with and without a family member with a BFRB.
Comorbid conditions and cognitive variables are presented in Table 2. Those with a
family history positive for SUD reported significantly higher rates of co-occurring ADHD
(p=.001). There were no significant differences in terms of comorbidities between those with and
without a family history of BFRBs. No significant cognitive differences were found based on
family history.
4. Discussion
The study confirms previous research showing that BFRBs are familial,13,14,19,20
as
-
7/25/2019 1-s2.0-S0010440X15303175-main
10/20
CCEP
TEDM
ANUSC
RIPT
ACCEPTED MANUSCRIPT
very early on as self-soothing mechanisms in response to the potentially chaotic environments.
Another possible, non-mutually exclusive, explanation is that a family history of SUDs may
reflect a shared genetic/biologic etiology for picking and pulling (for example neuroimaging
evidence suggests a possible shared circuitry involving orbitofrontal cortices, anterior cingulate
cortices, and neuro regions such as the right inferior frontal gyrus and the pre-supplementary
motor area involved in conditioned responses and response suppression).36,37In these
individuals, picking and pulling may function like an addiction and, although it awaits future
research, may even have a shared neurocircuitry with addictions.
In terms of co-occurring disorders, those with a family history of SUDs had higher rates
of comorbid ADHD. In light of the other findings, the elevated rates of ADHD in these
individuals could mean that some sort of impulsivity is familial and gives rise to ADHD, more
picking and pulling, and substance addictions. Some support for this comes from a recent study
of response inhibition in adults with trichotillomania, their first-degree relatives, and healthy
controls. Those with trichotillomania demonstrated impaired performance versus controls, with
first-degree relatives occupying an intermediate position, thereby suggestive of some familial
-
7/25/2019 1-s2.0-S0010440X15303175-main
11/20
CCEP
TEDM
ANUSC
RIPT
ACCEPTED MANUSCRIPT
incorporate behavioral elements addressing this issue specifically, or at least impulsivity more
generally, as well as the picking and pulling. Finally, one recent pharmacological treatment study
found that those adults with trichotillomania and a positive family history for alcoholism
responded to the opioid antagonist, naltrexone, whereas those without this family history did
not.39
Whether family history reflects viable subtypes within BFRBs that could improve
treatment remains uncertain as this time.
Although BFRBs have long been known to run in families, we found no evidence that the
presence or absence of this familial link results in a different clinical presentation. One
explanation could be that the BFRB family history simply did not differentiate the specific
clinical variables we examined. Whether it could be a meaningful variable for other aspects of
BFRBs remains unanswered. Additionally, whether this family history may be associated with
treatment response has also not been examined.
5. Conclusions
This study is the first to compare clinical measures based on two family history analyses
-
7/25/2019 1-s2.0-S0010440X15303175-main
12/20
CCEP
TEDM
ANUSC
RIPT
ACCEPTED MANUSCRIPT
the data from those with trichotillomania and those with skin picking disorder could have
obscured the findings for either group alone. Finally, no interviews of family members were
conducted and so these results may under- or over-estimate the family rates of BFRBs and
SUDs.
-
7/25/2019 1-s2.0-S0010440X15303175-main
13/20
CCEP
TEDM
ANUSC
RIPT
ACCEPTED MANUSCRIPT
References
1. Christenson GA, Mackenzie TB, Mitchell JE. Characteristics of 60 adult chronic hair pullers.
Am J Psychiatry1991;148:365-70.
2. Woods DW, Flessner CA, Franklin ME, Keuthen NJ, Goodwin RD, Stein DJ, Walther MR,
Board TLC-SA. The Trichotillomania Impact Project (TIP): exploring phenomenology,
functional impairment, and treatment utilization.J Clin Psychiatry2006;67:1877-88.
3. Grant JE, Odlaug BL, Chamberlain SR, Keuthen NJ, Lochner C, Stein DJ. Skin picking
disorder.Am J Psychiatry2012;169:1143-9.
4. Grant JE, Stein DJ. Body-focused repetitive behavior disorders in ICD-11.Rev Bras Psiquiatr
2014;36Suppl 1:59-64.
5. Mansueto C, Rogers K. Trichotillomania. In: Grant J, editor. Trichotillomania, skin picking,
and other body focused repetitive behaviors, Arlington, VA: American Psychiatric
Publishing; 2012, p. 175-92.
6. Christenson GA, Mansueto CS. Trichotillomania: Descriptive characteristics and
-
7/25/2019 1-s2.0-S0010440X15303175-main
14/20
CCEP
TEDM
ANUSC
RIPT
ACCEPTED MANUSCRIPT
10. Snorrason I, Belleau EL, Woods DW. How related are hair pulling disorder
(trichotillomania) and skin picking disorder? A review of evidence for comorbidity,
similarities and shared etiology. Clin Psychol Rev2012;32:618-29.
11. Mannino FV, Delgado RA. Trichotillomania in children: a review.Am J Psychiatry
1969;126:505-11.
12. Kerbeshian J, Burd L. Familial trichotillomania. Am J Psychiatry. 1991;148:684-5.
13. Christenson GA, Mackenzie TB, Reeve EA. Familial trichotillomania.Am J Psychiatry
1992;149:283.
14. Schlosser S, Black DW, Blum N, Goldstein RB. The demography, phenomenology, and
family history of 22 persons with compulsive hair pulling.Ann Clin Psychiatry
1994;6:147-52.
15. Odlaug BL, Grant JE. Trichotillomania and Pathologic Skin Picking: clinical comparison
with an examination of comorbidity.Ann Clin Psychiatry2008;20:57-63.
16. Snorrason I, Ricketts EJ, Flessner CA, Franklin ME, Stein DJ, Woods DW. Skin picking
disorder is associated with other body-focused repetitive behaviors: findings from an
-
7/25/2019 1-s2.0-S0010440X15303175-main
15/20
CCEP
TEDM
ANUSC
RIPT
ACCEPTED MANUSCRIPT
20. Novak CE, Keuthen NJ, Stewart SE, Pauls DL. A twin concordance study of
trichotillomania.Am J Med Genet B Neuropsychiatr Genet2009;150B:944-9.
21. Monzani B, Rijsdijk F, Harris J, Mataix-Cols D. The structure of genetic and environmental
risk factors for dimensional representations of DSM-5 obsessive-compulsive spectrum
disorders.JAMA Psychiatry2014;71:182-9.
22. Arnold LM, McElroy SL, Mutasim DF, Dwight MM, Lamerson CL, Morris EM.
Characteristics of 34 adults with psychogenic excoriation.J Clin Psychiatry
1998;59:509-14.
23. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-
Patient Edition (SCID-I/P, Version 2.0).New York: Biometrics Research Department,
New York State Psychiatric Institute; 1995.
24. Grant, JE.Impulse control disorders: a clinician's guide to understanding and treating
behavioral addictions.1st ed. New York: W. W. Norton & Company; 2008.
25. Guy W. ECDEU Assessment Manual for Psychopharmacology. In: US Dept Health,
Education and Welfare publication (ADM). Rockville, MD: National Institute of Mental
-
7/25/2019 1-s2.0-S0010440X15303175-main
16/20
CCEP
TEDM
ANUSC
RIPT
ACCEPTED MANUSCRIPT
30. Logan GD, Cowan WB, Davis KA. On the ability to inhibit simple and choice reaction time
responses: a model and a method.J Exp Psychol, Hum Percept Perform1984;10:276-91.
31. Owen AM, Roberts AC, Polkey CE, Sahakian BJ, Robbins TW. Extra-dimensional versus
intra-dimensional set shifting performance following frontal lobe excisions, temporal
lobe excisions or amygdalo-hippocampectomy in man.Neuropsychologia1991;29:993-
1006.
32. Lezak MD, Howieson DB, Loring DW.Neuropsychological Assessment.New York: Oxford
University Press; 2004.
33. Rosen B.Fundamentals of Biostatistics. 4th
Ed. Belmont, CA: Duxbury Press; 1995.
34. Grant JE, Odlaug BL, Potenza MN. Addicted to hair pulling? How an alternate model of
trichotillomania may improve treatment outcome.Harv Rev Psychiatry2007;15:80-5.
35. Emshoff JG, Price AW. Prevention and Intervention Strategies With Children of Alcoholics.
Pediatrics 1999;103:1112-21.
36. Chamberlain SR, Hampshire A, Menzies LA, Garyfallidis E, Grant JE, Odlaug BL et al.
Reduced brain white matter integrity in trichotillomania: a diffusion tensor imaging
-
7/25/2019 1-s2.0-S0010440X15303175-main
17/20
CCEP
TEDM
ANUSC
RIPT
ACCEPTED MANUSCRIPT
39. Grant JE, Odlaug BL, Schreiber LR, Kim SW. The opiate antagonist, naltrexone, in the
treatment of trichotillomania: results of a double-blind, placebo-controlled study.J Clin
Psychopharmacol2014; 34:134-8.
-
7/25/2019 1-s2.0-S0010440X15303175-main
18/20
ACCEPTED
MANUSCRI
PT
ACCEPTED MANUSCRIPT
17
Table 1: Demographic and Clinical Variables in 265 Body-Focused Repetitive Behaviors (BFRBs) Subjects With and Without
First-Degree Relatives with BFRBs or Substance Use Disorders (SUDs)
BFRB SUD
With 1st
DegreeRelativewith BFRB
(N=77)
Without 1st
DegreeRelativewith BFRB
(N=188)
Statistic p-value
With 1st
DegreeRelative withSUD
(N=59)
Without 1st
DegreeRelativewith SUD
(N=206)
Statistic p-value
DEMOGRAPHICS
Age (years) 34.4(11.4) 32.7 (11.2) 6656.5 .304 33.9 (11.4) 33.0 (11.2) 5782.5 .339
Age at Onset (years) 12.3 (6.8) 13.0 (7.9) 7034.0 .718 13.4 (9.3) 12.7 (7.0) 6069.0 .988
Sex, N (%),Female 70 (90.9) 167 (88.8) 1.269* .530 54 (91.5) 183 (88.8) .816* .665
Race, N(%),
Caucasian70 (90.9) 161 (85.6) 8.752* .119 48 (81.4) 183 (88.8) 9.649* .086
CLINICALTime spent in past
week pulling or
picking(minutes/day)
97.6(84.3) 86.6 (68.7) 4450.0 .606 117.9 (90.7) 81.7 (65.8) 3129.0 .022
Clinical Global
Impression-Severity4.44 (0.8) 4.40 (0.7) 7184.0 .914 4.5 (0.8) 4.4 (0.7) 5493.0 .202
Sheehan Disability
Scale10.8 (6.7) 10.8 (6.5) .003
+.955 10.7 (6.9) 10.9 (6.4) .027
+.870
Quality of Life
Inventory (T-score)43.5 (10.1) 43.0 (12.6) 7042.0 .963 42.0 (12.2) 43.5 (11.8) 5498.0 .339
Hamilton DepressionRating Scale
4.2 (3.5) 4.4 (3.6) 6984.0 .652 5.2 (3.6) 4.1 (3.5) 4982.0 .034
Hamilton Anxiety
Rating Scale4.3 (3.6) 4.3 (3.4) 7220.0 .975 5.1 (3.8) 4.1 (3.4) 5142.5 .070
History of BFRB
Treatment, N (%)37 (48.1) 74 (39.4) 1.695* .193 24 (40.7) 87 (42.2) .046* .831
All items are Mean (SD) unless noted
Statistics are Mann-Whitney Test (U) unless noted, *Chi-Square Test,+ANOVA (F), P-Value Bonferroni Corrected is significant at
.007.
-
7/25/2019 1-s2.0-S0010440X15303175-main
19/20
ACCEPTED
MANUSCRI
PT
ACCEPTED MANUSCRIPT
18
BFRB: Body-Focused Repetitive Behaviors, SUD= Substance Use Disorder, N=Number of subjects, %=Percent of Subjects
Table 2: Comorbidities and Neurocognitive Variables in Body-Focused Repetitive Behaviors (BFRB) Subjects With and
Without First-Degree Relatives with BFRBs or Substance Use Disorders (SUDs)
BFRB SUDWith 1st
Degree
Relative
with BFRB(N=77)
Without 1st
Degree
Relative
with BFRB(N=188)
Statistic p-value
With 1st
Degree
Relative with
SUD(N=59)
Without 1st
Degree
Relative
with SUD(N=206)
Statistic p-value
COMORBIDITIES
Major Depressive
Disorder, N (%)28 (36.4) 72 (38.3) .087* .768 24 (40.7) 76 (36.9) .280* .597
Any Anxiety
Disorder, N (%)15 (19.5) 37 (19.7) .001* .970 11 (18.6) 41 (19.9) .046* .830
Obsessive
Compulsive
Disorder, N (%)
6 (7.8) 9 (4.8) .924* .336 4 (6.7) 11 (5.3) .1788* .673
Attention Deficit
Hyperactivity
Disorder, N (%)
8 (10.4) 17 (9.0) .116* .733 12 (20.3) 13 (6.3) 10.564* .001
Any Lifetime
Disorder, N (%)42 (54.5) 100 (53.2) .040* .841 37 (62.7) 105 (51.0) 2.542* .111
COGNITIVE VARIABLES
Stop Signal ReactionTime
a 186.2 (65.7) 191.7 (68.7) 2711.5 .729 202.3 (86.9) 186.3 (60.5) 2279.0 .795
Intra-
Dimensional/Extra-
Dimensional Set-
Shift Task: Extra-
Dimensional Shiftb
9.9 (10.5) 8.6 (9.8) 2745.5 .694 9.5 (10.1) 8.8 (10.0) 2318.5 .322
Intra-Dimensional
/Extra-Dimensional24.3 (20.1) 21.5 (21.9) 2604.0 .372 22.3 (19.0) 22.3 (22.2) 2367.0 .421
-
7/25/2019 1-s2.0-S0010440X15303175-main
20/20
ACCEPTED
MANUSCRI
PT
ACCEPTED MANUSCRIPT
19
Set-Shift Task:
Total Errorsb
All items are Mean (SD) unless noted
Statistics are Mann-Whitney Test (U) unless noted, *Chi Square Test, P-value Bonferroni corrected is significant at .01
BFRB=Body-Focused Repetitive Behaviors, SUD= Substance Use Disorder, N=Number of subjects, %=Percent of subjectsa.Sample sizes differ for this variable: with 1stdegree relative with BFRB: n=117; without 1stdegree relative with BFRB: n=48; with 1 stdegree relative withSUD: n=126; without 1
stdegree relative with SUD: n=39.
b. Sample sizes differ for these variables: with 1stdegree relative with BFRB: n=119; without 1
stdegree relative with BFRB: n=48; with 1
stdegree relative with
SUD: n=126; without 1stdegree relative with SUD: n=41.